Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/21/2025

Treatment of Painless Epiphora

Initial Diagnostic Approach

  • The absence of pain or irritation in epiphora cases narrows the differential, excluding inflammatory conditions and infectious keratitis, according to the American Academy of Ophthalmology 1, 2, 3

Treatment Algorithm Based on Etiology

For Reflex Tearing (Ocular Surface Dysfunction)

  • The British Journal of Dermatology recommends initiating ocular lubricants, such as carboxymethylcellulose 0.5-1%, carmellose sodium, or hyaluronic acid drops, for patients with epiphora due to dry eye or meibomian gland dysfunction 4
  • The American Academy of Ophthalmology suggests adding lipid-containing eye drops for patients with meibomian gland dysfunction, and applying petrolatum ointment at night, especially if nocturnal lagophthalmos exists 4
  • The American Academy of Ophthalmology recommends considering anti-inflammatory treatment, such as topical cyclosporine or lifitegrast, for underlying dry eye disease 5, 6

For Anatomical Obstruction

  • The American Academy of Ophthalmology recommends treating ocular surface disease first with lubricants and anti-inflammatory agents, then correcting anatomical abnormalities, and finally addressing nasolacrimal obstruction if persistent 5, 6

Critical Pitfalls to Avoid

  • The American Academy of Ophthalmology advises against premature surgical intervention, ensuring ocular surface optimization before proceeding to lacrimal surgery, as reflex tearing may resolve with medical management 5
  • The American Academy of Ophthalmology warns against paradoxical epiphora caused by over-occlusion with punctal plugs, and recommends cautious trial punctal occlusion 5, 7, 6

Stepwise Management Strategy

  • The American Academy of Ophthalmology recommends a stepwise management strategy, starting with ruling out reflex tearing by treating any identified ocular surface disease with appropriate lubricants and anti-inflammatory therapy 5, 4, 6